Clinical Trial Update: Duloxetine for Chronic Depression: a Double-blind Study [Phase 4]

View source ↗

Summary

Phase 4 double-blind trial of duloxetine in chronic depression, including dysthymic disorder and depressive disorder NOS, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder Nos
• Dysthymic Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Dysthymic Disorder, Depressive Disorder NOS | Phase 4 | Status: COMPLETED | Results posted: 2015-11-03